BioSpace News Archive

BioMidwest

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program

Alzamend Neuro, Inc. announced that it has terminated its “at-the-market” equity offering program relating to sales of common stock with Ascendiant Capital Markets, LLC, as sales agent.

May 7, 2024
·
3 min read
Business

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months ended March 31, 2024 on Tuesday, May 14, 2024 after the close of trading on the U.S. financial markets.

May 7, 2024
·
2 min read
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists - May 7 2024

Equillium , Inc. today announced that a poster was presented at IMMUNOLOGY2024, the annual meeting of The American Association of Immunologists.

May 7, 2024
·
6 min read
Business

Avinger to Announce First Quarter 2024 Results on May 15, 2024

Avinger, Inc. today announced that it will release its financial results for the first quarter 2024 after the close of trading on Wednesday, May 15, 2024.

May 7, 2024
·
1 min read
Genetown

Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference

Wave Life Sciences Ltd. (Nasdaq: WVE) today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 8:30 a.m. ET.

May 7, 2024
·
1 min read
Business

Palisade Bio Appoints Margery Fischbein to its Board of Directors

Palisade Bio, Inc. announced it has appointed Margery Fischbein to its Board of Directors.

May 7, 2024
·
4 min read
Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure’s ProSense®, Adding to Continued Positive Data Published Globally

IceCure Medical Ltd. announced that positive data from an independent study performed in Japan was published in an article titled “Percutaneous ultrasound–guided cryoablation for early–stage primary breast cancer: a follow–up study in Japan,” in the journal Breast Cancer on April 27, 2024.

May 7, 2024
·
6 min read
Deals

Baxter Declares Quarterly Dividend - May 7, 2024

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.

May 7, 2024
·
1 min read
Bio NC

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

Precision BioSciences, Inc. (Nasdaq: DTIL) today announced that its partner iECURE has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ECUR-506.

May 7, 2024
·
11 min read
Drug Development

Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that data from the Phase 3 MARCH-PFIC study evaluating LIVMARLI® (maralixibat) oral solution in patients with PFIC was published in The Lancet Gastroenterology and Hepatology.

May 7, 2024
·
8 min read